# Filing Detail

Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-24-059407
Filing Date
2024-03-05
Accepted
2024-03-05 17:15:28
Documents
126

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | POS AM | d518298dposam.htm iXBRL | POS AM | 2810147
2 | EX-5.1 | d518298dex51.htm | EX-5.1 | 8023
3 | EX-23.1 | d518298dex231.htm | EX-23.1 | 1402
4 | EX-23.2 | d518298dex232.htm | EX-23.2 | 1456
10 | GRAPHIC | g518298g0305152730469.jpg | GRAPHIC | 2179
11 | GRAPHIC | g518298g0305152730761.jpg | GRAPHIC | 2141
12 | GRAPHIC | g518298g08m07.jpg | GRAPHIC | 112060
13 | GRAPHIC | g518298g40p53.jpg | GRAPHIC | 123237
14 | GRAPHIC | g518298g61v60.jpg | GRAPHIC | 103695
15 | GRAPHIC | g518298g68p81.jpg | GRAPHIC | 64161
16 | GRAPHIC | g518298g81i79.jpg | GRAPHIC | 35007
17 | GRAPHIC | g518298g82k34.jpg | GRAPHIC | 88399
| Complete submission text file | 0001193125-24-059407.txt |  | 13371165

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA | syre-20231231.xsd | EX-101.SCH | 90333
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | syre-20231231_cal.xml | EX-101.CAL | 59200
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | syre-20231231_def.xml | EX-101.DEF | 529955
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | syre-20231231_lab.xml | EX-101.LAB | 730925
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | syre-20231231_pre.xml | EX-101.PRE | 683371
128 | EXTRACTED XBRL INSTANCE DOCUMENT | d518298dposam_htm.xml | XML | 1769665

Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-273769 | Film No.: 24722261
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)